These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703 [TBL] [Abstract][Full Text] [Related]
5. Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component. Jugler C; Sun H; Grill F; Kibler K; Esqueda A; Lai H; Li Y; Lake D; Chen Q Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632528 [TBL] [Abstract][Full Text] [Related]
6. Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Frigerio R; Marusic C; Villani ME; Lico C; Capodicasa C; Andreano E; Paciello I; Rappuoli R; Salzano AM; Scaloni A; Baschieri S; Donini M Front Plant Sci; 2022; 13():956741. PubMed ID: 36131799 [TBL] [Abstract][Full Text] [Related]
7. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Mamedov T; Yuksel D; Ilgın M; Gürbüzaslan I; Gulec B; Mammadova G; Ozdarendeli A; Yetiskin H; Kaplan B; Islam Pavel ST; Uygut MA; Hasanova G Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835268 [TBL] [Abstract][Full Text] [Related]
8. Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In Mamedov T; Gurbuzaslan I; Yuksel D; Ilgin M; Mammadova G; Ozkul A; Hasanova G Front Plant Sci; 2021; 12():742875. PubMed ID: 34938305 [TBL] [Abstract][Full Text] [Related]
9. Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities. Diego-Martin B; González B; Vazquez-Vilar M; Selma S; Mateos-Fernández R; Gianoglio S; Fernández-Del-Carmen A; Orzáez D Front Plant Sci; 2020; 11():612781. PubMed ID: 33424908 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody. Jugler C; Sun H; Chen Q Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835296 [TBL] [Abstract][Full Text] [Related]
11. Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2. Siriwattananon K; Manopwisedjaroen S; Kanjanasirirat P; Budi Purwono P; Rattanapisit K; Shanmugaraj B; Smith DR; Borwornpinyo S; Thitithanyanont A; Phoolcharoen W Front Plant Sci; 2020; 11():604663. PubMed ID: 33584747 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Hurtado J; Acharya D; Lai H; Sun H; Kallolimath S; Steinkellner H; Bai F; Chen Q Plant Biotechnol J; 2020 Jan; 18(1):266-273. PubMed ID: 31207008 [TBL] [Abstract][Full Text] [Related]
13. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development. Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK Front Immunol; 2020; 11():1880. PubMed ID: 32973779 [TBL] [Abstract][Full Text] [Related]
14. Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Boonyayothin W; Sinnung S; Shanmugaraj B; Abe Y; Strasser R; Pavasant P; Phoolcharoen W Front Plant Sci; 2021; 12():683417. PubMed ID: 34249053 [TBL] [Abstract][Full Text] [Related]
16. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein. Goo J; Jeong Y; Park YS; Yang E; Jung DI; Rho S; Park U; Sung H; Park PG; Choi JA; Seo SH; Cho NH; Lee H; Lee JM; Kim JO; Song M Virus Res; 2020 Mar; 278():197863. PubMed ID: 31945421 [TBL] [Abstract][Full Text] [Related]
18. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425 [TBL] [Abstract][Full Text] [Related]
19. The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests. Williams L; Jurado S; Llorente F; Romualdo A; González S; Saconne A; Bronchalo I; Martínez-Cortes M; Pérez-Gómez B; Ponz F; Jiménez-Clavero MÁ; Lunello P Front Plant Sci; 2021; 12():699665. PubMed ID: 34386028 [TBL] [Abstract][Full Text] [Related]
20. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Huang Z; Phoolcharoen W; Lai H; Piensook K; Cardineau G; Zeitlin L; Whaley KJ; Arntzen CJ; Mason HS; Chen Q Biotechnol Bioeng; 2010 May; 106(1):9-17. PubMed ID: 20047189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]